Pedro Lichtinger files SEC Form 4 disclosures for OPTIMER PHARMACEUTICALS INC. They have made 7 open-market trades across 4 companies since 2011, most recently 2019-07-24.
CIK 0001638287
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $1.1M since 2011, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GEMP | BUY | 2017-03-10 | 2017-03-14 | $9.47 | $200K | +30.4% | +23.9% | +16.0% |
| GEMP | BUY | 2016-08-10 | 2016-08-12 | $10.00 | $100K | +4.7% | +26.3% | -3.3% |
| AST | BUY | 2015-02-09 | 2015-02-11 | $3.90 | $500K | -32.5% | -2.1% | -2.1% |
| OPTR | SELL | 2013-04-08 | 2013-04-10 | $14.69 | $2.2M | N/A | N/A | N/A |
| OPTR | BUY | 2012-11-08 | 2012-11-19 | $9.08 | $100K | N/A | N/A | N/A |
| BTX | BUY | 2012-04-11 | 2012-04-12 | $3.98 | $25K | +7.4% | -0.1% | -0.1% |
| OPTR | BUY | 2011-08-04 | 2011-08-04 | $8.98 | $225K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.